A CARCINOGENICITY STUDY IN MICE OF A BETA-ADRENERGIC ANTAGONIST, PRIMIDOLOL - INCREASED TOTAL TUMOR-INCIDENCE WITHOUT TISSUE-SPECIFICITY

被引:15
作者
FACCINI, JM [1 ]
IRISARRI, E [1 ]
MONRO, AM [1 ]
机构
[1] PFIZER LABS,CTR RECH,PFIZER CENT RES,F-37400 AMBOISE,FRANCE
关键词
D O I
10.1016/0300-483X(81)90143-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:279 / 290
页数:12
相关论文
共 35 条
[1]  
Alcock SJ, 1964, P EUR SOC STUD DRUG, V4, P30
[2]   HISTOPATHOLOGY OF PRIMARY LUNG TUMOURS IN MOUSE [J].
AMARALME.JJ .
JOURNAL OF PATHOLOGY, 1969, 97 (03) :415-&
[3]  
BOYD H, 1977, MOL PHARMACOL, V13, P576
[4]  
BRITTAIN RT, 1979, PHARM BIOCH PROPERTI, V2, P229
[5]   EXPERIENCE WITH MUTAGENIC TESTS AS INDICATORS OF CARCINOGENIC ACTIVITY [J].
CINKOTAI, KI ;
JONES, CC ;
TOPHAM, JC ;
WATKINS, PA .
MUTATION RESEARCH, 1978, 53 (02) :167-168
[6]  
CLINE JC, 1977, RES COMMUN CHEM PATH, V16, P523
[7]  
FITZGERALD JD, 1979, PHARM BIOCH PROPERTI, V2, P98
[8]  
GRASSO P, 1972, FOOD COSMET TOXICOL, V10, P418
[9]  
GRASSO P, 1975, MOUSE HEPATIC NEOPLA, P111
[10]  
HARMS HH, 1978, BRIT J CLIN PHARMACO, V5, P19, DOI 10.1111/j.1365-2125.1978.tb01593.x